These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24814244)

  • 1. Interferon-gamma responses in sheep exposed to virulent and attenuated Brucella melitensis strains.
    Pérez-Sancho M; Durán-Ferrer M; García-Seco T; Macías P; García N; Martínez I; Ruiz E; Legaz E; Diez-Guerrier A; González S; Domínguez L; Álvarez J
    Vet Immunol Immunopathol; 2014 Jul; 160(1-2):123-8. PubMed ID: 24814244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
    Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterisation of monoclonal antibodies to Brucella melitensis cytosoluble proteins that are able to differentiate antibody responses of infected sheep from Rev. 1 vaccinated sheep.
    Cloeckaert A; Debbarh HS; Zygmunt MS; Dubray G
    J Med Microbiol; 1996 Sep; 45(3):206-13. PubMed ID: 8810948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute infection by conjunctival route with Brucella melitensis induces IgG+ cells and IFN-gamma producing cells in peripheral and mucosal lymph nodes in sheep.
    Suraud V; Jacques I; Olivier M; Guilloteau LA
    Microbes Infect; 2008 Oct; 10(12-13):1370-8. PubMed ID: 18761416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes.
    Verger JM; Grayon M; Zundel E; Lechopier P; Olivier-Bernardin V
    Vaccine; 1995 Feb; 13(2):191-6. PubMed ID: 7625115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep.
    Pérez-Sancho M; Adone R; García-Seco T; Tarantino M; Diez-Guerrier A; Drumo R; Francia M; Domínguez L; Pasquali P; Álvarez J
    Vaccine; 2014 Apr; 32(16):1877-81. PubMed ID: 24508034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
    Muñoz PM; de Miguel MJ; Grilló MJ; Marín CM; Barberán M; Blasco JM
    Vaccine; 2008 May; 26(21):2562-9. PubMed ID: 18423950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant BP26 protein in serological diagnosis of Brucella melitensis infection in sheep.
    Cloeckaert A; Baucheron S; Vizcaino N; Zygmunt MS
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):772-5. PubMed ID: 11427425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
    Higgins JL; Bowen RA; Gonzalez-Juarrero M
    Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the CP24 protein of Brucella melitensis lack diagnostic usefulness in ovine brucellosis.
    Delpino MV; Cassataro J; Fossati CA; Baldi PC
    Vet Microbiol; 2003 May; 93(2):101-7. PubMed ID: 12636998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ; Marín CM; Barberán M; de Miguel MJ; Laroucau K; Jacques I; Blasco JM
    Vaccine; 2009 Jan; 27(2):187-91. PubMed ID: 19007836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O:9 in pigs.
    Riber U; Jungersen G
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):13-25. PubMed ID: 17270281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive enzyme-linked immunosorbent assay using monoclonal antibodies to the Brucella melitensis BP26 protein to evaluate antibody responses in infected and B. melitensis Rev.1 vaccinated sheep.
    Debbarh HS; Zygmunt MS; Dubray G; Cloeckaert A
    Vet Microbiol; 1996 Dec; 53(3-4):325-37. PubMed ID: 9008343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA; Laroucau K; Olivier M; Grillo MJ; Marin CM; Verger JM; Blasco JM
    Vaccine; 2006 Apr; 24(17):3461-8. PubMed ID: 16519974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.